^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CD147-CAR T cells

    i
    Other names: CD147-CAR T cells, CAR T cells targeting CD147
    Associations

    News

    Trials
    Company:
    Peking University People's Hospital
    Drug class:
    CD147-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over3years
    CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma (clinicaltrials.gov)
    P1, N=12, Not yet recruiting, Peking University People's Hospital | Trial completion date: Jan 2024 --> Jan 2025 | Initiation date: Oct 2021 --> Jan 2023 | Trial primary completion date: Jan 2023 --> Jan 2024
    Trial completion date • Trial initiation date • Trial primary completion date • CAR T-Cell Therapy
    |
    ALK (Anaplastic lymphoma kinase) • BSG (Basigin (Ok Blood Group))
    |
    ALK positive • ALK negative
    |
    CD147-CAR T cells